CD8A and esophageal squamous cell carcinoma: Their analysis unveiled a distinctive link between sprouty RTK signaling antagonist 1 (SPRY1) expression and exhausted CD8+ T cells, suggesting a potential therapeutic target for reversing the immunosuppressive TME in ESCC.